LBA-03 EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)

International Journal of Urology ◽

10.1111/iju.13359 ◽

2017 ◽

Vol 24 (7) ◽

pp. 525-531 ◽

Cited By ~ 11

Author(s):

Tomonori Yamanishi ◽

Hirotaka Asakura ◽

Narihito Seki ◽

Shoji Tokunaga

Keyword(s):

Overactive Bladder ◽

Combination Therapy ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Direct Study ◽

The Efficacy and Safety of Combination Therapy with Alpha-Blocker and Low-Dose Propiverine Hydrochloride for Benign Prostatic Hyperplasia Accompanied by Overactive Bladder Symptoms

Korean Journal of Urology ◽

10.4111/kju.2009.50.11.1078 ◽

2009 ◽

Vol 50 (11) ◽

pp. 1078 ◽

Cited By ~ 4

Author(s):

Kang Il Seo ◽

Sung Zoo Hong ◽

Jong Bouk Lee

Keyword(s):

Overactive Bladder ◽

Combination Therapy ◽

Low Dose ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Alpha Blocker ◽

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

The Journal of Urology ◽

10.1097/ju.0000000000000738 ◽

2020 ◽

Vol 203 (6) ◽

pp. 1163-1171 ◽

Cited By ~ 7

Author(s):

Steven A. Kaplan ◽

Sender Herschorn ◽

Kevin T. McVary ◽

David Staskin ◽

Christopher Chapple ◽

...

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

A 52‐week multicenter randomized controlled study of the efficacy and safety of add‐on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study)

LUTS Lower Urinary Tract Symptoms ◽

10.1111/luts.12243 ◽

2018 ◽

Vol 11 (3) ◽

pp. 115-121 ◽

Cited By ~ 2

Author(s):

Tomonori Yamanishi ◽

Hirotaka Asakura ◽

Narihito Seki ◽

Shoji Tokunaga

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Randomized Controlled Study ◽

Controlled Study ◽

Efficacy And Safety ◽

Direct Study ◽

Randomized Controlled ◽

Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia

Current Urology Reports ◽

10.1007/s11934-020-01017-7 ◽

2021 ◽

Vol 22 (1) ◽

Author(s):

Gregory R. Mullen ◽

Steven A. Kaplan

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Solifenacin or Mirabegron Could Improve Persistent Overactive Bladder Symptoms After Dutasteride Treatment in Patients With Benign Prostatic Hyperplasia

Urology ◽

10.1016/j.urology.2015.01.028 ◽

2015 ◽

Vol 85 (5) ◽

pp. 1151-1155 ◽

Cited By ~ 10

Author(s):

Takahiro Maeda ◽

Eiji Kikuchi ◽

Masanori Hasegawa ◽

Katsura Ishioka ◽

Masayuki Hagiwara ◽

...

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia

LUTS Lower Urinary Tract Symptoms ◽

10.1111/luts.12406 ◽

2021 ◽

Author(s):

Dongu Lee ◽

Kyo Chul Koo ◽

Jeong Woo Yoo ◽

Kwang Suk Lee

Keyword(s):

Overactive Bladder ◽

Prostatic Hyperplasia ◽

MP-01.01: The effect of anticholinergics to benign prostatic hyperplasia patients with overactive bladder symptoms and the risk factors to affect patient's satisfaction

Urology ◽

10.1016/j.urology.2010.07.345 ◽

2010 ◽

Vol 76 (3) ◽

pp. S9

Author(s):

W. Cho ◽

T. Kim ◽

J. Yoon

Keyword(s):

Risk Factors ◽

Overactive Bladder ◽

Prostatic Hyperplasia ◽

Patient’S Satisfaction ◽

Efficacy of adding mirabegron to alpha-adrenoreceptor blocker in patients with benign prostatic hyperplasia with persistent overactive bladder symptoms: A prospective study

Investigative and Clinical Urology ◽

10.4111/icu.2020.61.4.419 ◽

2020 ◽

Vol 61 (4) ◽

pp. 419

Author(s):

Se Yun Kwon ◽

Dong Jin Park ◽

Young Jin Seo ◽

Kyung Seop Lee

Keyword(s):

Overactive Bladder ◽

Prospective Study ◽

Prostatic Hyperplasia ◽

Bladder Symptoms ◽

A Prospective Study

Clinical efficacy of an α1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia

International Journal of Urology ◽

10.1111/j.1442-2042.2006.01222.x ◽

2006 ◽

Vol 13 (1) ◽

pp. 15-20 ◽

Cited By ~ 37

Author(s):

SATORU TAKAHASHI ◽

ATSUSHI TAJIMA ◽

HISASHI MATSUSHIMA ◽

TAKESHI KAWAMURA ◽

TAKASHI TOMINAGA ◽

...

Keyword(s):

Overactive Bladder ◽

Clinical Efficacy ◽

Prostatic Hyperplasia ◽

Adrenoceptor Blocker ◽